Literature DB >> 28945223

Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms.

L-N Fu1, Y-Q Wang1, J Tan1, J Xu1, Q-Y Gao1, Y-X Chen1, J-Y Fang1.   

Abstract

Metabolic stress is a common phenomenon in solid tumors. Compensatory mechanisms to overcome metabolic stress (glucose deprivation) are vital to tumor cell survival. The histone demethylase Jumonji domain-containing protein 2B (JMJD2B) is vital for the growth and progression of various cancers. However, the role of JMJD2B during glucose deprivation remains unclear. Our aim was to examine the function of JMJD2B in glucose-deprived colon cancer cells and the involvement of extracellular signal-regulated kinase (ERK) and glucose transporter 1 (GLUT1). Our study demonstrated that JMJD2B expression was upregulated via ERK phosphorylation during glucose deprivation. Further, the cell viability assay showed that the effect of p-ERK on the viability of colon cancer cells was at least partly dependent on JMJD2B expression. Glucose deprivation increased interaction between JMJD2B and p-ERK, as demonstrated by the co-immunoprecipitation and fluorescence assays. Glucose deprivation also resulted in phosphorylation of JMJD2B by p-ERK, as shown by the immunoprecipitation assay and western blotting analysis. In addition, the phosphorylation of JMJD2B via p-ERK at Thr305, Ser352, Ser566 and Thr1065 contribute to JMJD2B stability. p-ERK stabilizes the JMJD2B protein level by protecting JMJD2B from ubiquitination and proteasome degradation. We found that knockdown of JMJD2B significantly impaired colon cancer cell viability, which is accompanied by a significant reduction in glucose uptake and lactate production. Furthermore, knockdown of JMJD2B after glucose deprivation caused decreased level of GLUT1 through increasing H3K9 tri-methylation levels on its promoter, demonstrated by chromatin immunoprecipitation assay. Moreover, targeting JMJD2B in xenograft tumors also decreased the GLUT1 level. Finally, a positive correlation was observed between p-ERK, JMJD2B and GLUT1 expression in 85 human colon cancer tissue specimens. These results indicated that p-ERK-mediated phosphorylation and stabilization of JMJD2B during glucose deprivation contributes to its role in glucose uptake and cell viability, which may be modulated through epigenetically upregulation of GLUT1.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28945223     DOI: 10.1038/onc.2017.345

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

Review 1.  Transcriptional regulation by the MAP kinase signaling cascades.

Authors:  Shen-Hsi Yang; Andrew D Sharrocks; Alan J Whitmarsh
Journal:  Gene       Date:  2003-11-27       Impact factor: 3.688

2.  Histone demethylation by a family of JmjC domain-containing proteins.

Authors:  Yu-ichi Tsukada; Jia Fang; Hediye Erdjument-Bromage; Maria E Warren; Christoph H Borchers; Paul Tempst; Yi Zhang
Journal:  Nature       Date:  2005-12-18       Impact factor: 49.962

Review 3.  When signaling kinases meet histones and histone modifiers in the nucleus.

Authors:  Sung Hee Baek
Journal:  Mol Cell       Date:  2011-05-06       Impact factor: 17.970

4.  Relevance of the MEK/ERK signaling pathway in the metabolism of activated macrophages: a metabolomic approach.

Authors:  Paqui G Través; Pedro de Atauri; Silvia Marín; María Pimentel-Santillana; Juan-Carlos Rodríguez-Prados; Igor Marín de Mas; Vitaly A Selivanov; Paloma Martín-Sanz; Lisardo Boscá; Marta Cascante
Journal:  J Immunol       Date:  2011-12-21       Impact factor: 5.422

Review 5.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

6.  Lactate promotes resistance to glucose starvation via upregulation of Bcl-2 mediated by mTOR activation.

Authors:  Chen Huang; Shile Sheng; Rui Li; Xiaoguang Sun; Jianju Liu; Gang Huang
Journal:  Oncol Rep       Date:  2014-12-08       Impact factor: 3.906

Review 7.  Angiogenesis and apoptosis.

Authors:  Judah Folkman
Journal:  Semin Cancer Biol       Date:  2003-04       Impact factor: 15.707

Review 8.  Regulation of gene transcription by mitogen-activated protein kinase signaling pathways.

Authors:  Alan J Whitmarsh
Journal:  Biochim Biophys Acta       Date:  2006-11-17

9.  The histone H3K36 demethylase Rph1/KDM4 regulates the expression of the photoreactivation gene PHR1.

Authors:  Chung-Yi Liang; Pang-Hung Hsu; Dai-Fang Chou; Chao-Yu Pan; Long-Chi Wang; Wei-Chieh Huang; Ming-Daw Tsai; Wan-Sheng Lo
Journal:  Nucleic Acids Res       Date:  2011-02-03       Impact factor: 16.971

10.  Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer.

Authors:  L Chen; L Fu; X Kong; J Xu; Z Wang; X Ma; Y Akiyama; Y Chen; J Fang
Journal:  Br J Cancer       Date:  2014-01-28       Impact factor: 7.640

View more
  12 in total

Review 1.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 2.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

3.  Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling.

Authors:  Huanyu Zhao; Jian Sun; Jianshuang Shao; Zifang Zou; Xueshan Qiu; Enhua Wang; Guangping Wu
Journal:  J Cancer       Date:  2019-08-27       Impact factor: 4.207

4.  KDM4B facilitates colorectal cancer growth and glucose metabolism by stimulating TRAF6-mediated AKT activation.

Authors:  Haijie Li; Jingqin Lan; Guihua Wang; Kaixuan Guo; Caishun Han; Xiaolan Li; Junbo Hu; Zhixin Cao; Xuelai Luo
Journal:  J Exp Clin Cancer Res       Date:  2020-01-13

5.  Enterotoxigenic Bacteroides fragilis induces the stemness in colorectal cancer via upregulating histone demethylase JMJD2B.

Authors:  Qian-Qian Liu; Chun-Min Li; Lin-Na Fu; Hao-Lian Wang; Juan Tan; Yun-Qian Wang; Dan-Feng Sun; Qin-Yan Gao; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Gut Microbes       Date:  2020-07-20

6.  Post-translational modification analysis of Saccharomyces cerevisiae histone methylation enzymes reveals phosphorylation sites of regulatory potential.

Authors:  Ryan J Separovich; Mandy W M Wong; Tyler R Chapman; Eve Slavich; Joshua J Hamey; Marc R Wilkins
Journal:  J Biol Chem       Date:  2020-12-20       Impact factor: 5.157

Review 7.  The role of histone methylation in the development of digestive cancers: a potential direction for cancer management.

Authors:  Yuan Chen; Bo Ren; Jinshou Yang; Huanyu Wang; Gang Yang; Ruiyuan Xu; Lei You; Yupei Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-08-03

8.  LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc.

Authors:  Jiayin Tang; Tingting Yan; Yujie Bao; Chaoqin Shen; Chenyang Yu; Xiaoqiang Zhu; Xianglong Tian; Fangfang Guo; Qian Liang; Qiang Liu; Ming Zhong; Jinxian Chen; Zhizheng Ge; Xiaobo Li; Xiaoyu Chen; Yun Cui; Yingxuan Chen; Weiping Zou; Haoyan Chen; Jie Hong; Jing-Yuan Fang
Journal:  Nat Commun       Date:  2019-08-02       Impact factor: 14.919

9.  JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy.

Authors:  Juan Tan; Hao-Lian Wang; Jie Yang; Qian-Qian Liu; Chun-Min Li; Yun-Qian Wang; Lin-Na Fu; Qin-Yan Gao; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Theranostics       Date:  2020-04-27       Impact factor: 11.556

10.  Association of JMJD2B and Hypoxia-Inducible Factor 1 Expressions with Poor Prognosis in Osteosarcoma.

Authors:  Xujian Liu; Qianqian Zhang; Yi Zhao; Jianjun Xun; Hongzeng Wu; Helin Feng
Journal:  Anal Cell Pathol (Amst)       Date:  2020-07-31       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.